AGLE · Categories · 13G

AGLE - SEC Schedule 13G filings

Aeglea BioTherapeutics Inc. (AGLE) sec schedule 13g filings - real-time wire coverage filtered to 13G only.

Recent 13G for AGLE

• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 840d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 841d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 841d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 841d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 841d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 842d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 845d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 846d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 903d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 915d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Spyre Therapeutics, Inc. (0001636282) (Subject)
• 932d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1041d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1051d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1059d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1066d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1069d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1069d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1205d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1205d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1205d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1205d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1205d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1206d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1216d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1240d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1280d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1455d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1570d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1570d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1570d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1573d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1574d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1574d
  SEC Form SC 13G filed by Aeglea BioTherapeutics Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1574d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1581d
  SEC Form SC 13G/A filed by Aeglea BioTherapeutics Inc. (Amendment)

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1630d
  SEC Form SC 13G filed by Aeglea BioTherapeutics, Inc.

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1933d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1933d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1933d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1937d
  SEC Form SC 13G filed

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1937d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1938d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1939d
  SEC Form SC 13G filed

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1939d
  SEC Form SC 13G/A filed

  SC 13G/A - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)
• 1947d
  SEC Form SC 13G filed

  SC 13G - Aeglea BioTherapeutics, Inc. (0001636282) (Subject)

Other AGLE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends